Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Hemp, Inc (HEMP)
Las Vegas, NV, US
Hemp, Inc. operates primarily within the industrial hemp sector. Its diverse product range includes various hemp-derived offerings, such as their "King of Hemp" pre-roll blends, fortified pre-rolls, Bubba Kush hemp flower, specialized caviar/moon rocks, and concentrated diamonds and crumbles. Beyond retail products, the company is actively involved in the cultivation and processing of industrial hemp, alongside the extraction of CBD oil. It also plays a crucial role in empowering and educating hemp farmers and entrepreneurs, supplying them with vital knowledge, processing capabilities, infrastructure, and general support. Furthermore, Hemp, Inc. offers a wide array of hemp-related accessories and equipment for sale, encompassing extractors, harvesters, storage solutions, various containers, fertilizers, soil amendments, humidity control devices (humidifiers and dehumidifiers), balers, and comprehensive greenhouse systems. The firm extends its services to other hemp cultivators, providing post-harvest activities such as drying, trimming, curing, storing, and brokering harvested hemp. Complementing these activities, it also conducts research and development, offers professional hemp consulting, and delivers engaging educational entertainment. Established in 2008, the company initially operated as Marijuana, Inc. before officially rebranding to Hemp, Inc. in June 2012. Its corporate headquarters are located in Las Vegas, Nevada.
Based on only 1 article — low confidence
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +4,900.00% | +4,900.00% | +4,900.00% | +4,900.00% | +4,900.00% | +4,900.00% | -50.00% | -99.32% | -99.88% | -99.95% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%+333.7% ★ Q4'22: +511.5% (vs Q4'21)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+88.9% ★ Q4'22: +79.9% (vs Q4'21)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-1,179.9% Q4'22: -16,024.6% (vs Q4'21)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-1,688.7% Q4'22: -2,554.4% (vs Q4'21)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%-7.1% Q4'22: -5.4% (vs Q4'21)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+67.2% Q4'22: +67.2% (vs Q4'21)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×160.33×
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gary Perlowin | Chief Executive Officer, Chief Financial Officer & Director | — | — |
| James L. Hancock | President | — | male |
| Joseph Di Marco | Accounting Manager | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HEMP
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
